Current surgical management of malignant pleural mesothelioma
Malignant pleural mesothelioma is a rare in addition to rattling aggressive malignancy amongst an increasing incidence. Single-modality therapy has failed to better median survival. Current surgical therapies include palliative in addition to cytoreductive procedures. The rarity of the disease, the lack of randomized surgical studies, as well as the lack of a universally accepted together with validated staging organization arrive hard to accomplish consensus together with establish stage-specific protocols. However, alongside strict criteria, subsets of patients can live identified who can benefit from aggressive cytoreductive surgical approaches, such as extrapleural pneumonectomy, too adjuvant chemoradiation protocols. Our feel with this type of protocol inwards carefully selected patients has resulted in increased median survival. The lack of cure in whatsoever of the published protocols demonstrates the require for novel therapies in addition to approaches for this disease.
Malignant pleural mesothelioma is a rare in addition to rattling aggressive malignancy amongst an increasing incidence. Single-modality therapy has failed to better median survival. Current surgical therapies include palliative in addition to cytoreductive procedures. The rarity of the disease, the lack of randomized surgical studies, as well as the lack of a universally accepted together with validated staging organization arrive hard to accomplish consensus together with establish stage-specific protocols. However, alongside strict criteria, subsets of patients can live identified who can benefit from aggressive cytoreductive surgical approaches, such as extrapleural pneumonectomy, too adjuvant chemoradiation protocols. Our feel with this type of protocol inwards carefully selected patients has resulted in increased median survival. The lack of cure in whatsoever of the published protocols demonstrates the require for novel therapies in addition to approaches for this disease.
Advertisement
